maprotiline has been researched along with Hypoglycemia in 2 studies
Maprotiline: A bridged-ring tetracyclic antidepressant that is both mechanistically and functionally similar to the tricyclic antidepressants, including side effects associated with its use.
Hypoglycemia: A syndrome of abnormally low BLOOD GLUCOSE level. Clinical hypoglycemia has diverse etiologies. Severe hypoglycemia eventually lead to glucose deprivation of the CENTRAL NERVOUS SYSTEM resulting in HUNGER; SWEATING; PARESTHESIA; impaired mental function; SEIZURES; COMA; and even DEATH.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Zogno, MG | 1 |
| Tolfo, L | 1 |
| Draghi, E | 1 |
| Isotani, H | 1 |
| Kameoka, K | 1 |
2 other studies available for maprotiline and Hypoglycemia
| Article | Year |
|---|---|
Hypoglycemia caused by maprotiline in a patient taking oral antidiabetics.
Topics: Administration, Oral; Aged; Diabetes Mellitus, Type 2; Drug Interactions; Female; Glyburide; Humans; | 1994 |
Hypoglycemia associated with maprotiline in a patient with type 1 diabetes.
Topics: Adult; Antidepressive Agents, Second-Generation; Blood Glucose; C-Peptide; Depressive Disorder; Diab | 1999 |